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Abstract. 
 
We used melanophores, cells specialized for 
regulated organelle transport, to study signaling path-
ways involved in the regulation of transport. We trans-
 
fected immortalized 
 
Xenopus
 
 melanophores with plas-
mids encoding epitope-tagged inhibitors of protein 
phosphatases and protein kinases or control plasmids 
encoding inactive analogues of these inhibitors. Expres-
sion of a recombinant inhibitor of protein kinase A 
(PKA) results in spontaneous pigment aggregation. 
 
a
 
-Melanocyte-stimulating hormone (MSH), a stimulus 
which increases intracellular cAMP, cannot disperse 
pigment in these cells. However, melanosomes in these 
cells can be partially dispersed by PMA, an activator of 
protein kinase C (PKC). When a recombinant inhibitor 
of PKC is expressed in melanophores, PMA-induced 
pigment dispersion is inhibited, but not dispersion in-
duced by MSH. We conclude that PKA and PKC acti-
vate two different pathways for melanosome disper-
sion. When melanophores express the small t antigen of 
SV-40 virus, a specific inhibitor of protein phosphatase 
2A (PP2A), aggregation is completely prevented. Con-
versely, overexpression of PP2A inhibits pigment dis-
persion by MSH. Inhibitors of protein phosphatase 1 
and protein phosphatase 2B (PP2B) do not affect pig-
ment movement. Therefore, melanosome aggregation 
is mediated by PP2A.
Key words: microtubules • protein phosphorylation • 
microtubule motors • kinesin II • cytoplasmic dynein
 
M
 
elanophores
 
, pigment cells of lower verte-
brates, transport organelles containing the black
pigment melanin synchronously towards or
away from the cell center, providing the mechanism by
which fish and amphibia change color. Pigment aggrega-
tion and dispersion is dependent on the integrity of cyto-
plasmic microtubules (Murphy and Tilney, 1974; McNiven
and Porter, 1984) and actin filaments (Malawista, 1971;
McGuire and Moellmann, 1972; Rodionov et al., 1998;
Rogers and Gelfand, 1998), and is accomplished by micro-
tubule motors and by myosin (Clark and Rosenbaum,
1982; Rodionov et al., 1987; Rogers and Gelfand, 1998;
Rogers et al., 1997). In pigment cells, as in most other cells,
the minus ends of microtubules are connected with the
perinuclear centrosome, whereas the plus ends are located
at the cell periphery (Euteneuer and McIntosh, 1981). Ag-
gregation is mediated by the minus end–directed microtu-
bule motor cytoplasmic dynein (Nilsson and Wallin, 1997),
whereas dispersion is due to the coordinate activities of a
plus end microtubule motor and a myosin, most likely kine-
sin II and myosin V, respectively (Rogers and Gelfand, 1998;
Rogers et al., 1997). The signaling pathways and mecha-
nisms for regulating these motors are largely unknown.
Melanophores provide an excellent system for studying
molecular motor regulation because the movement of pig-
ment organelles is activated by known physiological sig-
nals. In the case of 
 
Xenopus
 
 
 
laevis
 
 melanophores, pigment
aggregation is triggered by melatonin, which binds to its
membrane receptor and reduces the concentration of
cAMP in the cytoplasm through the action of a coupled in-
hibitory G protein (White et al., 1987; Sugden, 1992). A
physiological signal for pigment dispersion is provided by
 
melanocyte-stimulating hormone (MSH)
 
1
 
, which increases
the intracellular concentration of cAMP (Daniolos et al.,
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1990). Thus, the direction of melanosome movement in
 
Xenopus
 
 melanophores correlates with the level of cAMP
in the cytoplasm. A similar correlation is found for other
pigment cells including
 
 Tilapia
 
 
 
mossambica 
 
melanophores
(Rozdzial and Haimo, 1986)
 
, Pteophyllum scalare
 
 melano-
phores (Sammak et al., 1992), and 
 
Carassius
 
 
 
auratus 
 
xan-
thophores (Palazzo et al., 1989).
Dispersion of pigment in melanophores can also be in-
duced by activators of PKC, such as phorbol esters,
mezerein, and diacylglycerol (Sugden and Rowe, 1992;
Graminski et al., 1993), and the hormone endothelin 3
(McClintock et al., 1996). Unlike MSH-induced disper-
sion, dispersion induced by phorbol esters causes the cell
to form fine dendritic processes (Sugden and Rowe, 1992),
and does not change the intracellular cAMP concentration
(Graminski et al., 1993), indicating that two different sig-
naling pathways are involved in dispersing pigment. We
directly addressed this question using specific recombinant
inhibitors of protein kinases. These proteins contain pep-
tide sequences derived from regulatory pseudosubstrate
regions of protein kinases and act as potent and selective
inhibitors of the enzymes in vivo.
Pigment dispersion requires the activity of protein ki-
nases and conversely, pigment aggregation requires the ac-
tivity of a phosphatase. The phosphatase inhibitor okadaic
acid has been shown to inhibit aggregation in 
 
Xenopus
 
 and
angelfish melanophores, implicating PP1 and/or PP2A
(Cozzi and Rollag, 1992; Sammak et al., 1992). On the
other hand, it has been reported that the Ca
 
2
 
1
 
/calmodulin-
dependent protein phosphatase, PP2B (calcineurin), is re-
quired for pigment aggregation in melanophores of the
African cichlid, 
 
Tilapia mossambica 
 
(Thaler and Haimo,
1990). To identify the phosphatase involved in aggregation
in 
 
Xenopus
 
 melanophores we used specific inhibitors of
PP1, PP2A, and PP2B. In addition, we overexpressed the
catalytic subunit of PP2A.
We demonstrate that the MSH-stimulated pathway for
melanosome dispersion depends solely on PKA activity
and does not require PKC. The PMA-activated PKC path-
way, on the other hand, can only partially disperse mel-
anosomes in the absence of PKA activity. In addition, we
show that PP2A, but not PP1 or PP2B, is required for mel-
anosome aggregation in 
 
Xenopus
 
 melanophores. We also
demonstrate differences in the pattern of protein phos-
phorylation on melanosomes purified from cells aggregat-
ing and dispersing pigment.
 
Materials and Methods
 
Cell Line
 
An immortalized cell line of melanophores from 
 
Xenopus laevis
 
 (gift of
M. Lerner, University of Texas Southwestern Medical Center, Dallas,
TX) was cultured at 27
 
8
 
C in 0.7
 
3
 
 L-15 medium (GIBCO BRL, Grand Is-
land, NY) supplemented with 5% fetal bovine serum (HyClone, Logan,
UT), 5 
 
m
 
g/ml insulin, and 100 
 
m
 
g/ml each of penicillin and streptomycin as
described (Daniolos et al., 1990; Rogers et al., 1997)
 
.
 
 Cells were trans-
ferred to the same medium without serum 24 h before induction of aggre-
gation or dispersion of melanosomes by hormones.
 
Constructs
 
We have prepared recombinant constructs that contain inhibitory se-
quences in the context of larger polypeptides under the control of the
 
Rous sarcoma virus promoter and rabbit 
 
b
 
-globin splicing/polyadenyla-
tion sites. We matched the structures of the recombinant PKC and Ca
 
2
 
1
 
/
calmodulin-dependent kinase II (CaMK) inhibitors to the sequences of
the short conserved peptides located at positions 19–36 in various forms of
protein kinase C (PKC) (House and Kemp, 1987) and positions 273–302
of CaMK (Smith et al., 1990, 1992), respectively. The recombinant PKA
inhibitors included sequences of the natural heat-stable protein kinase A
(PKA) inhibitor PKI (Van Patten et al., 1991). Mutant forms of the inhib-
itors carrying inactivating amino acid substitutions in the kinase recogni-
tion sequence served as controls. We selected the most potent inhibitors
based on their ability to antagonize the activation of reporter genes in cul-
tured cells by various stimuli (cAMP, PMA, Ca
 
2
 
1
 
, depolarization). The in-
hibitory activity of these constructs is high enough to completely prevent
the activation of a reporter promoter by the corresponding stimuli; this ac-
tion is specific, as mutant inactive constructs fail to block reporter induc-
tion. Furthermore, the activity of a particular inhibitor does not interfere
with the action of the nontarget kinases, reflecting vast differences (100–
10,000-fold) in dissociation constant (K
 
i
 
) for the cognate and for the unre-
lated enzymes in vitro. The recombinant inhibitor of protein phosphatase
1 (PP1) includes amino acids 9–54 of the natural rabbit skeletal muscle in-
hibitor I-1 with a threonine to aspartate mutation at amino acid 35 to
mimic phosphorylated threonine (Alberts et al., 1994). The protein phos-
phatase 2B (PP2B) inhibitor includes amino acids 457–482 of PP2B, the
autoinhibitory domain (Hashimoto et al., 1990). Each of the recombinant
proteins contains an epitope derived from the influenza virus hemaggluti-
nin protein (HA epitope) (Field et al., 1988) at the COOH-terminal end.
This tag allowed visualization of the chimeric products in the transfected
cells by fluorescence microscopy using the anti-HA monoclonal antibody
12CA5 (Field et al., 1988). Plasmids pNP210 and pNP211 encode the ac-
tive and inactive forms of the PKA inhibitor, respectively; pNP212 and
pNP214 encode the active and inactive forms of the PKC inhibitor;
pNP215 and pNP216 encode the active and inactive forms of the CaMK
inhibitor, pNP231 encodes the PP1 inhibitor I-1, and pNP241 encodes the
PP2B inhibitor (Table I).
Plasmid pCEP4-Sm t (gift of S. Shenolikar, Department of Pharmacol-
ogy, Duke University Medical Center, Durham, NC) encodes the full-
length wild-type SV-40 small t antigen, an inhibitor of protein phosphatase
2A (PP2A) (Alberts et al., 1994). A plasmid encoding green fluorescent
protein (GFP),
 
 
 
pEGFP-C
 
1 
 
(Clontech, Palo Alto, CA),
 
 
 
was used in control
transfections for the phosphatase inhibitors (see Results). pGRE5-2 (T) 36
encoding the PP2A C subunit tagged with an HA epitope-derived peptide
under the control of a dexamethasone-inducible promoter was a gift of D.
Pallas, (Department of Biochemistry and Winship Cancer Center, Emory
University School of Medicine, Atlanta, GA) (Ogris et al., 1997).
 
Transfections
 
NIH 3T3 fibroblasts were transfected with TransFast transfection reagent
(Promega Corp., Madison, WI) according to the manufacturer's protocol
and then incubated for 48 h in DME with 10% calf serum to allow protein
expression before the experiments were performed. Melanophores were
transfected by electroporation at 450 V, 200 ohms, and 250 microfarads
using a Bio-Rad Gene Pulser II (Bio-Rad Laboratories, Hercules, CA) ac-
cording to the protocol of Graminski et al. (1993) and then plated onto
10-cm tissue culture plates. They were replated onto polylysine-coated
coverslips 24 h later. The medium was changed to serum-free L-15 on the
third day; experiments were performed on the fourth day. Transfection ef-
ficiencies varied depending on the plasmid and on the transfection;
 
z
 
0.5% of cells transfected with pCEP4-Sm t stained positively for the
small t antigen, whereas inhibitor expression was detected in 10–50% of
cells transfected with the other plasmids.
 
Treatment With Drugs
 
For the experiments with okadaic acid, cells were incubated in serum-free
medium containing 0.5 nM-2 
 
m
 
M okadaic acid for 1.5 or 24 h before treat-
ment with 10 nM melatonin. Cyclosporin A (dissolved in 100% ethanol;
Calbiochem-Novabiochem, La Jolla, CA) and cypermethrin and fenvaler-
ate (in DMSO; Calbiochem-Novabiochem) were diluted into serum-free
medium and added to cells for preincubations of 1 h or overnight before
treatment with melatonin or MSH. To aggregate or disperse melano-
somes, cells were incubated in 10 nM melatonin (10 
 
m
 
M stock in ethanol),
100 nM MSH (100 
 
m
 
M stock in H
 
2
 
O), 1 mM 3-isobutyl-1-methyl xanthine
(IBMX; 500 mM stock in DMSO), or 1 
 
m
 
M PMA (100 
 
m
 
g/ml stock in
DMSO) for 60–90 min. Cells were scored as aggregated, partially dis- 
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persed, or fully dispersed according to the state of pigment aggregation.
Cells scored as fully aggregated had their melanosomes in a dense mass at
the center of the cell (for example see Fig. 5, 
 
A
 
 and 
 
G
 
). Cells scored as
partially dispersed had melanosomes that were released a short distance
from the central pigment mass (see Fig. 5 
 
C
 
). Cells scored as fully dis-
persed had melanosomes evenly distributed throughout the cytoplasm
(see Fig. 5, 
 
B
 
–
 
F
 
 and 
 
H
 
).
 
Immunofluorescence
 
To stain transfected melanophores, the cells were fixed in freshly pre-
pared 4% paraformaldehyde in 0.7
 
3 
 
PBS.
 
 
 
A monoclonal antibody that
recognizes both large and small t antigen, Ab-1, was obtained from Onco-
gene Research (Cambridge, MA), and used at 2 
 
m
 
g/ml. A cultured super-
natant containing monoclonal antibody 12CA5 that recognizes the HA
epitope (Field et al., 1988) was used at a dilution of 1:5. For double-stain-
ing with microtubules, cells were fixed with methanol at 
 
2
 
20
 
8
 
C. The anti-
body used for microtubule staining was an affinity-purified rabbit anti-
body to bovine brain tubulin (gift of A.A. Minin, Institute of Protein
Research, Russian Academy of Sciences, Moscow, Russia), and was used at
4.6 
 
m
 
g/ml. Secondary antibodies conjugated with rhodamine or fluorescein
were purchased from Jackson ImmunoResearch Laboratories, Inc. (West
Grove, PA), and used at a dilution of 1:100. All antibodies were diluted
into 1% BSA, 0.1% Triton X-100 in PBS. Cells were imaged with a Photo-
metrics (Tucson, AZ) CH250 charge-coupled device camera on a Zeiss
Axioskop, using a 40
 
3
 
/NA 1.3 Plan-Neofluar oil-immersion lens (both
from Carl Zeiss. Inc., Thornwood, NY). Oncor Image (Oncor, Inc., Gaith-
ersburg, MD) was used to acquire bright-field and fluorescence images,
and Adobe Photoshop (Adobe Systems, Inc., San Jose, CA) was used to
overlay the bright-field image (which clearly shows the distribution of
melanosomes) onto the fluorescent image.
For the experiments with NIH 3T3 fibroblasts, cells were treated 48 h
after transfection with 1 mM IBMX for 45 min. The IBMX was washed
out for 10 min before fixing the cells in 4% paraformaldehyde in PBS.
Cells were double-stained with a polyclonal antibody to phosphorylated
cAMP response element binding protein (CREB), used at a dilution of
1:200 (New England Biolabs Inc., Beverly, MA), and antibody 12CA5
which recognizes the HA epitope (Field et al., 1988), used at a dilution of
1:50. Transfected cells were scored as having phosphorylated CREB
present or absent from the nuclei.
 
Radioactive Labeling
 
Cells were grown to confluence on 10-cm plates and transferred into 10 ml
of phosphate-free DME (Sigma Chemical Co., St. Louis, MO) without se-
rum containing 0.025 mCi/ml 
 
32
 
P
 
i
 
 for 22–25 h. Pigment was induced to ag-
gregate with 10 nM melatonin or to disperse with 100 nM MSH, 1 mM
IBMX, or 0.1 
 
m
 
M PMA for 30 min. Melanosomes were purified in IMB50
buffer (50 mM imidazole, pH 7.4, 1 mM EGTA, 0.5 mM EDTA, 5 mM
magnesium acetate, 175 mM sucrose) supplemented with protease inhibi-
tors (1 mM PMSF, and 10 
 
m
 
g/ml each of chymostatin, leupeptin, and pep-
statin A [CLP]), according to Rogers et al. (1998), with the following mod-
ifications. To inhibit phosphatases and kinases, the IMB50 was
supplemented with 1 
 
m
 
M microcystin-LR (GIBCO BRL), 0.1 mM sodium
orthovanadate, 0.5 
 
m
 
M staurosporine (Sigma Chemical Co.), 1 
 
m
 
M PKI
(GIBCO BRL), and 1 mM EDTA. After lysing cells in 2 ml of buffer by
passing them through a 25-gauge hypodermic needle, unlysed cells were
removed by centrifugation at 2,000 rpm (650 
 
g
 
) for 2 min in a rotor (model
HB-6; Sorvall, Inc., Newtown, CT). The supernatant was layered onto
80% Percoll in IMB50 containing microcystin, staurosporine, PKI, PMSF,
and CLP, and then spun for 20 min at 10,000 rpm (16,300 
 
g
 
) in the HB-6
rotor. The pelleted melanosomes were resuspended directly into SDS
sample buffer.
 
Western Blots
 
Proteins were run on 7% SDS-PAGE gels and transferred to nitrocellu-
lose (Towbin et al., 1979). Blots were blocked overnight in 5% normal
goat serum, 0.1% Tween 20 in TBS. A mouse monoclonal antibody to
phoshothreonine, used at 0.5 
 
m
 
g/ml, and a polyclonal antibody to phos-
phoserine, used at 0.25 
 
m
 
g/ml, were from Zymed Laboratories (South San
Francisco, CA). Monoclonal antibody PY20 to phosphotyrosine (Trans-
duction Laboratories, Lexington, KY) was used at 2 
 
m
 
g/ml. Monoclonal
antibody K2.4 to the sea urchin kinesin II 85-kD subunit (gift of J. Scho-
ley, University of California, Davis, CA) (Cole et al., 1993) was used at a
 
1:200 dilution, and monoclonal antibody 70.1 to dynein intermediate chain
(Sigma Chemical Co.) was used at a dilution of 1:500. The secondary anti-
bodies were HRP goat anti–mouse or HRP goat anti–rabbit (Jackson Im-
munoResearch Laboratories, Inc.), diluted 1:10,000. All antibodies were
diluted into blocking buffer. SuperSignal (Pierce Chemical Co., Rockford,
IL) was used for secondary antibody detection.
 
Immunoprecipitations
 
Cells were labeled with 
 
32
 
P
 
i 
 
and induced to aggregate or disperse pigment
as described above. The cells were rinsed briefly in 10 mM Hepes, 150 mM
NaCl, pH 7.3, to remove the medium, then lysed with 150 
 
m
 
L lysis buffer
per 10-cm plate. The lysis buffer contained 1% Triton X-100, 50 mM
Tris-HCL, pH 8.0, 50 mM NaCl, 2 mM EGTA, 2 mM EDTA, 1 mM
 
b
 
-mercaptoethanol, and was supplemented with the protease, kinase, and
phosphatase inhibitors described above for purification of melanosomes.
Extracts were spun at 14,000 rpm for 10 min in an Eppendorf tabletop
centrifuge (model 5415C; Hamburg, Germany), then at 70,000 rpm for 20
min in a TLA100.3 rotor in a TL-100 ultracentrifuge (Beckman Instrs.,
Palo Alto, CA). Extracts were precleared for 1.5 h with 10 
 
m
 
L of normal
mouse serum or normal rabbit serum prebound to protein A beads. The
precleared extracts were incubated for 12 h at 4
 
8
 
C with 2.5 
 
m
 
L of mono-
clonal antibody 74.1 to the dynein intermediate chain (gift of K. Pfister,
University of Virginia Health Science Center, Charlottesville, VA)
(Dillman and Pfister, 1994) or 4 
 
m
 
L of rabbit polyclonal antibody to
KIF3B (the mouse homologue of the kinesin II 95-kD subunit; gift of V.
Muresan and B. Schnapp, Harvard University Medical School, Boston,
MA) (Muresan et al., 1998). Pelleted beads were washed twice with lysis
buffer, once with lysis buffer containing 0.5 M NaCl, and once more with
lysis buffer. Beads were resuspended in 25 
 
m
 
L 2
 
3
 
 Laemmli sample buffer
(Laemmli, 1970).
 
Results
 
Effects of Protein Phosphatase Inhibitors on 
Melanosome Movement
 
We used inhibitors of protein phosphatases to determine
which phosphatases are involved in pigment aggregation
by melatonin. Melanosomes in the 
 
Xenopus
 
 cell line are
normally dispersed throughout the cytoplasm in the ab-
sence of treatment with hormones, and aggregate in re-
sponse to melatonin. Treatment of the cells with okadaic
acid blocked melanosome aggregation by melatonin at a
concentration of 500 nM when the cells were incubated for
1.5 h with the drug before treatment, and at 125 nM when
they were preincubated for 25 h with the drug. We consid-
ered it necessary to incubate the cells with okadaic acid
overnight because melanophores are cultured at 27
 
8
 
C, and
it has been reported that the half-time for okadaic acid in-
flux through the cell membrane is over 1 h at 37
 
8
 
C and
over 4 h at 25
 
8
 
C (Namboodiripad and Jennings, 1996).
However, our results, like those of previous studies (Cozzi
and Rollag, 1992; Sammak et al., 1992) could not distin-
guish between PP1 and PP2A for playing a role in melano-
some aggregation (the K
 
i
 
 for okadaic acid inhibition for
PP1 is 20–315 nM, and for PP2A it is 0.1–2 nM). We there-
fore sought to distinguish between these phosphatases by
the use of more specific inhibitors.
To test the involvement of PP1 in pigment aggregation,
we constructed plasmid pNP231 encoding constitutively
active inhibitor I (Alberts et al., 1994), an endogenous
pseudosubstrate inhibitor of PP1, tagged with an epitope
from the influenza virus HA so that transfected cells could
be visualized by immunofluorescent staining with anti-
body 12CA5 (Field et al., 1988). We tested the activity of
the HA-tagged inhibitor of PP1 by taking advantage of the 
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fact that PP1 mediates dephosphorylation of CREB (Al-
berts et al., 1994; Hagiwara et al., 1992). When constitu-
tively active inhibitor 1 is overexpressed in NIH 3T3 fibro-
blasts, it increases CREB phosphorylation and prevents its
dephosphorylation after stimulation of cells with 8-bromo-
cAMP and IBMX (a phosphodiesterase inhibitor) (Al-
berts et al., 1994). We therefore transfected 3T3 cells with
pNP231 encoding the HA-tagged inhibitor 1, or with
pNP211 encoding an HA-tagged inactive peptide (de-
scribed in detail below) to control for the effects of trans-
fection and expression of an HA-tagged peptide on CREB
phosphorylation. Transfected cells were incubated with
1 mM IBMX to induce CREB phosphorylation, then
rinsed with PBS and incubated an additional 10 min in me-
dium without IBMX to allow CREB to become dephos-
phorylated. Immunofluorescent staining with an antibody
against phosphorylated CREB showed that phospho-
CREB levels in the nuclei declined in both control cells
and cells expressing the PP1 inhibitor after washing out
the IMBX, but the disappearance of phosphoCREB from
the nucleus was inhibited in cells expressing the inhibitor
(data not shown). Having verified the activity of the HA-
tagged PP1 inhibitor, we transfected melanophores with
the plasmid encoding the inhibitor and found that its ex-
pression had no effect on pigment aggregation or disper-
sion induced by melatonin or MSH, respectively. We
therefore conclude that PP1 is not involved in the regula-
tion of pigment movement in melanophores.
To test the involvement of PP2A in pigment aggrega-
tion, we transfected melanophores with a plasmid encod-
ing the SV-40 small t antigen, which binds to PP2A and in-
hibits its activity (Yang et al., 1991; Sontag et al., 1993).
Expression of the small t antigen resulted in nearly a com-
plete block of pigment aggregation by melatonin (Fig. 1).
As a control we transfected cells with a plasmid encoding
GFP to score the amount of aggregation and dispersion in
transfected cells (Fig. 1). We observed that the transfec-
tion procedure itself induced some cells to aggregate mel-
anosomes, but virtually all such control cells were able to
disperse pigment in the presence of MSH. To indepen-
dently confirm that PP2A is necessary for pigment aggre-
gation, we performed a reverse experiment overexpressing
the epitope-tagged catalytic subunit of PP2A in melano-
phores to determine if an excess of PP2A could bias pig-
ment towards an aggregated state. Cells overexpressing
PP2A, identified by immunofluorescent staining with the
HA antibody, had relatively high levels of expressed pro-
tein in the nucleus and a mixture of diffuse and punctate
staining in the cytoplasm, a localization previously de-
scribed for PP2A (Turowski et al., 1995). If PP2A is re-
quired for pigment aggregation, overexpression of PP2A
might be expected to cause cells to aggregate pigment.
However, cells overexpressing PP2A did not spontane-
ously aggregate pigment, perhaps because PP2A activity
requires activation by melatonin. After inducing pigment
aggregation with melatonin in cells overexpressing PP2A,
we observed an inhibition of pigment dispersion by 1 nM
MSH (Fig. 2). However, this inhibition can be overcome
by increasing MSH to 10 nM. The level of PP2A overex-
pression previously achieved with this plasmid was only
10–50% (Ogris et al., 1997), so the relatively modest effect
on inhibition of dispersion is not surprising. Since the in-
tracellular concentration of cAMP in melanophores in-
creases with increasing concentrations of MSH applied to
the cell (Potenza and Lerner, 1992) it is likely that this low
amount of overexpressed PP2A was sufficient only to
counteract a low level of intracellular cAMP.
Since PP2A colocalizes with microtubules (Sontag et al.,
1995) and is involved in the control of microtubule dynam-
ics during mitosis (Tournebize et al., 1997), we wanted to
eliminate the possibility that inhibition or overexpression
of PP2A might be altering microtubule number or stabil-
ity. Cells expressing the small t antigen or overexpressing
PP2A were treated with melatonin or MSH, fixed, and
then double-stained for microtubules with a polyclonal tu-
bulin antibody and either the small t antigen or the HA-
derived epitope tagging the PP2A catalytic subunit. Cells
expressing the small t antigen and cells overexpressing
PP2A had a normal density and distribution of microtu-
bules (data not shown). We therefore conclude that PP2A
is required in the signaling pathway for melanosome ag-
gregation.
We also tested the involvement of PP2B in pigment ag-
gregation in 
 
Xenopus
 
 melanophores since it has been re-
 
Table I. List of Plasmids Encoding Inhibitors of Protein Kinases and Protein Phosphatases and Summary of Their Effects on 
Hormone-induced Melanosome Movement
 
Encoded protein Plasmid
Melatonin
(aggregation)
MSH
(dispersion)
PMA
(dispersion)
Melatonin
 
1
 
 PMA
 
PKA inhibitor, active pNP210
 
1
 
*
 
2
 
‡
 
6
 
§
 
6
 
PKA inhibitor, inactive pNP211
 
11 1 1
 
PKC inhibitor, active pNP212
 
11 1 2
 
PKC inhibitor, inactive pNP214
 
11 1 1
 
CAMKII inhibitor, active pNP215
 
11 1 1
 
CAMKII inhibitor, inactive pNP216
 
11 1 1
 
small t (PP2A inhibitor) pCEP4-Sm t
 
21
 
PP1 inhibitor pNP231
 
11
 
PP2B inhibitor pNP241
 
11
 
GFP pEGFP-C
 
1
 
11
 
PP2A pGRE5-2 (T) 36
 
12
 
*Dispersion or aggregation occurs normally.
 
‡
 
No dispersion or aggregation.
 
§
 
Dispersion is partially inhibited. 
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ported that PP2B is required for aggregation in fish mela-
nophores (Thaler and Haimo, 1990). We treated cells with
two types of pharmacological inhibitors to PP2B. Cy-
closporin A binds to the intracellular protein cyclophilin
to form a complex which binds to and inactivates PP2B
with nanomolar affinity (Liu et al., 1991). Treatment of
melanophores with 1 
 
m
 
M of cyclosporin A neither affected
the ability of cells to aggregate pigment in the presence of
10 nM of melatonin nor to disperse pigment in the pres-
ence of 100 nM MSH. Therefore, even a high cyclosporin
A concentration had no effect on the movement of pig-
ment in melanophores. We also used two inhibitors of
PP2B in the type II pyrethroid class of drugs, cyper-
methrin and fenvalerate (Enan and Matsumura, 1992).
Doses ranging from 1–50 nM cypermethrin (50% inhibi-
tory concentration [IC
 
50
 
] is 40 pM) and 20 nM–2 
 
m
 
M fen-
valerate (IC
 
50
 
 is 2–4 nM) failed to have an effect on aggre-
gation or dispersion of pigment induced by melatonin or
MSH, respectively. In addition, we transfected melano-
phores with a plasmid encoding a recombinant PP2B in-
hibitor based on the pseudosubstrate domain of PP2B
(Hashimoto et al., 1990). Expression of this inhibitor pep-
tide had no effect on pigment aggregation or dispersion in-
duced by melatonin or MSH. We therefore conclude that
PP2B is not involved in the regulation of pigment move-
ment in 
 
Xenopus
 
 melanophores.
 
Effects of Protein Kinase Inhibitors on
Pigment Dispersion
 
To study the role of protein kinases in melanosome move-
ment, we used highly selective recombinant inhibitors of
protein kinases. These inhibitors were derived from the
pseudosubstrate inhibitory regions of PKC and CaMK,
and the endogenous heat stable PKA inhibitor, PKI
(Soderling, 1990; Kemp et al., 1991; Walsh and Glass,
1991). The recombinant inhibitors are highly effective and
specific, and were used to dissect the signaling cascades ac-
tivated by Ca
 
2
 
1
 
 influx in neuronal cells (Peunova, N.I., and
G.N. Enikolopov, manuscript in preparation). Mutant
forms of the inhibitors carrying inactivating amino acid
substitutions in the kinase recognition sequence (Grove
et al., 1987; House and Kemp, 1987; Waldmann et al.,
1990)
 
 
 
served as controls for the effects of the transfection
procedure and the accumulation of large amounts of pep-
tide in the cells.
 
Expression of the PKA Inhibitor
 
Melanosomes disperse when the cAMP level is high, as
when cells are treated with MSH, and aggregate when
cAMP is low, which occurs when cells are treated with me-
latonin. In the absence of melatonin or MSH, melano-
phores grow in culture with melanosomes in a dispersed
Figure 1. Inhibition of PP2A by the small t antigen blocks mel-
anosome aggregation. (A) Melanophores transfected with plas-
mids encoding the small t antigen or GFP were treated with 10 nM
melatonin for 90 min and fixed with formaldehyde. Cells express-
ing the small t antigen were identified by immunofluorescent
staining with an antibody against the SV-40 small t antigen. The
vertical axis shows the percentage of cells that were scored as ag-
gregated (white), partially dispersed (grey), or dispersed (black).
Scoring was done as described in Materials and Methods. Note
the almost complete inhibition of pigment aggregation in the
small t-expressing cells. The data are from over 400 small t-express-
ing and over 500 GFP-expressing cells from three separate exper-
iments. (B) A cell expressing small t maintained its pigment in a
dispersed state after melatonin treatment (left), whereas a GFP
control cell aggregated pigment normally (right). The cells are
shown by overlaying bright-field images onto fluorescent images.
Bar, 20 mm.
Figure 2. Overexpression of PP2A inhibits melanosome disper-
sion at low levels of cAMP. Cells transfected with plasmids en-
coding the HA-tagged PP2A catalytic subunit or GFP were
treated with 25 mM dexamethasone for 24 h to induce PP2A ex-
pression. Cells were then treated with 10 nM melatonin for 1 h to
aggregate pigment, followed by 1 nM or 10 nM MSH for 30 min.
PP2A-expressing cells were identified by immunofluorescent
staining with an antibody to HA, and 100 cells were scored per
treatment. The data is from a typical experiment; similar results
were obtained in three independent experiments.The Journal of Cell Biology, Volume 142, 1998 808
state (Fig. 3 A). To determine whether this steady-state
dispersion depends solely on the level of active PKA, we
transfected melanophores with plasmid pNP210 encoding
the epitope-tagged specific PKA inhibitor. After 48–72 h,
a significant number of cells in the transfected culture had
fully aggregated melanosomes (Fig. 3 B). Nontransfected
cells and cells transfected with plasmid pNP211 encoding
an epitope-tagged inactive analogue of PKI maintained
their melanosomes in the dispersed state (Fig. 3, A and C).
We confirmed that the aggregated cells in the pNP210 cul-
ture were expressing the inhibitor by immunofluorescent
staining for the HA tag. Therefore, the steady-state dis-
persion of melanosomes depends on PKA activity.
When cells expressing the PKA inhibitor were treated
with MSH, virtually all the transfected cells stayed com-
pletely aggregated even after prolonged incubation in
MSH, demonstrating that PKA was effectively inhibited
(Fig. 4 and Fig. 5 A). In control experiments in which mel-
Figure 3. Phase-contrast images of nontransfected cells (A), and
cells transfected with the PKA inhibitor plasmid (B), or with the
plasmid encoding the inactive analogue of the inhibitor (C). Af-
ter 72 h, a large percentage of cells in the culture expressing the
active inhibitor had fully aggregated pigment. Control cells main-
tained their melanosomes in the dispersed state. Bar, 50 mm.
Figure 4. Quantitative analysis of the effects of the active and in-
active PKA and PKC inhibitor peptides on melanosome aggrega-
tion and dispersion. Cells expressing the PKA inhibitor aggre-
gated their pigment and could not disperse it when treated with
MSH. These cells partially dispersed melanosomes in response to
PMA. Cells expressing the inactive PKA inhibitor dispersed mel-
anosomes normally in response to MSH and PMA. Cells express-
ing the PKC inhibitor dispersed pigment when treated with MSH,
but were inhibited from dispersing pigment after aggregation
with melatonin and treatment with PMA. Percentages are from
scoring 200 cells per treatment. Similar results were obtained in
at least three other independent experiments with each inhibitor.Reilein et al. Regulation of Organelle Transport 809
anophores were transfected with plasmid pNP211 encod-
ing the inactive inhibitor, typically 50% of the HA-positive
cells had partially-dispersed pigment after transfection,
and virtually all of them dispersed pigment after treatment
with MSH (Fig. 4 and Fig. 5 B). The same result was ob-
served in GFP-transfected cells; therefore, pigment aggre-
gation is the result of the transfection procedure itself
rather than expression of the inactive inhibitor. To rule
out the possibility that microtubule disassembly was re-
sponsible for the inability of cells expressing the active
PKA inhibitor to disperse pigment, we fixed cells and per-
formed double staining for microtubules and the HA
epitope. Both transfected and nontransfected cells con-
tained an elaborate array of microtubules radiating from
the cell center (data not shown). Furthermore, the density
of the microtubule network in transfected and nontrans-
fected cells did not differ.
Having shown that expression of the PKA inhibitor
completely inhibited dispersion by MSH, we tested
whether activation of PKC could disperse melanosomes in
the absence of PKA activity. The PKC activator PMA can
override melatonin-induced aggregation and disperse pig-
ment even in the presence of melatonin (Sugden and
Rowe, 1992). Since melatonin acts by reducing cAMP
(Daniolos et al., 1990), PKC may be signaling pigment dis-
persion through an alternate pathway. When cells express-
ing the PKA inhibitor were aggregated with melatonin
and then treated with 1 mM of PMA to activate PKC, in
most cells the melanosomes were released from the cen-
tral aggregate a short distance to become partially dis-
persed (Fig. 5 C), and in 17% of the cells pigment dis-
persed to the tips of the processes. Identical treatment of
cells transfected with the control plasmid pNP211 resulted
in full dispersion of 86% of cells (Fig. 4 and Fig. 5 D). We
conclude that PKC can partially disperse pigment in the
absence of active PKA, but requires a basal level of PKA
activity to induce full dispersion.
Expression of the PKC and CaMK Inhibitors
It is possible that a component in the pathway for melano-
some movement might require phosphorylation by both
PKA and PKC for full activation. Having found that PKC
requires some PKA activity for full dispersion, we also
considered the reverse question, whether the PKA path-
way requires any PKC activity. Previous studies have
shown that a pharmacological inhibitor of PKC, Ro 31-
8220, did not block MSH-induced dispersion (Sugden and
Rowe, 1992; McClintock et al., 1996). The very high speci-
ficity of the peptide inhibitor of PKC used together with
its inactive control provided a tool to address this question
more definitively.
Unlike expression of the PKA inhibitor, expression of
the active inhibitor of PKC from plasmid pNP212 did not
induce aggregation of pigment (Fig. 4), and the appear-
ance of cultures transfected with active and inactive inhib-
itor constructs was identical. pNP212-transfected cells
could still aggregate melanosomes in the presence of mela-
tonin, but PMA-induced dispersion of cells treated with
melatonin was inhibited compared with dispersion in cells
transfected with the inactive control plasmid pNP214 (Fig.
4 and Fig. 5, G and H). All cells expressing the PKC inhib-
itor dispersed pigment in the presence of MSH (Fig. 5, E
and F), confirming the studies showing that PKA-medi-
ated dispersion is PKC independent.
We also wanted to test the involvement of CaMK in pig-
ment movement because calcium levels in fish melano-
phores have been shown to rise with aggregation (Sam-
mak et al., 1992). We transfected cells with plasmid
pNP215 encoding a peptide inhibitor to CaMK, and with a
Figure 5. Immunofluorescent staining of cells expressing HA-
tagged inhibitor and control peptides and treated with MSH or
PMA to induce pigment dispersion. Cells in A–D were trans-
fected with plasmids encoding the active (A and C) or inactive (B
and D ) PKA inhibitors, and treated with MSH (A and B) or
PMA (C and D). Cells in E–H were transfected with plasmids en-
coding the active (E and G) or inactive (F and H) PKC inhibitors,
and treated with MSH (E and F) or PMA (G and H). Cells ex-
pressing the PKA inhibitor were blocked from dispersing mel-
anosomes in response to MSH, whereas expression of the control
peptide did not prevent dispersion by MSH. Treatment with
PMA resulted in only partial pigment dispersion in cells express-
ing the PKA inhibitor, although cells expressing the control pep-
tide dispersed pigment normally. Expression of either the active
or inactive PKC inhibitor did not prevent MSH-induced disper-
sion of pigment after aggregation by melatonin. PMA-induced
dispersion was prevented by the active but not the control inhibi-
tor. Bar, 20 mm.The Journal of Cell Biology, Volume 142, 1998 810
control plasmid, pNP216. The CaMK inhibitor has been
shown to specifically block CaMK activity in cultured cells
(Peunova, N.I., and G.N. Enikolopov, manuscript in prep-
aration); however, it had no effect on pigment motility in
melanophores.
Phosphorylation Targets in Cells Aggregating and 
Dispersing Pigment
Ultimately, the signaling pathways regulating pigment trans-
port should activate or inhibit motor proteins responsible for
organelle movement. To identify phosphorylation targets of
PKA and PKC, we purified melanosomes from cells labeled
with 32Pi. Cells were induced to disperse pigment with MSH,
IBMX (a phosphodiesterase inhibitor) or PMA (an activa-
tor of PKC), or aggregate pigment with melatonin.
Labeled melanophore cell extract has a complex pattern
of phosphorylated bands (Fig. 7). When melanosomes are
purified from labeled cells, the pattern of phosphorylation
is much simpler than in the total cell extract. Most bands
are equally phosphorylated on aggregating and dispersing
melanosomes except for a region of mol wt 87–95 kD (Fig.
6  A). Melatonin-treated melanosomes show a heavily-
phosphorylated band at 95 kD, whereas IBMX- and MSH-
treated melanosomes show phosphorylation at 87 kD, and
untreated and PMA-treated melanosomes have a band of
broad phosphorylation from 88–92 kD.
Blots of melanosomes probed with an anti-phosphothre-
onine antibody show a similar pattern of phosphorylation
in the mol wt region of 87–95 kD, and the heavier phos-
phorylation in melatonin-treated cells is even more obvi-
ous (Fig. 6 B). Blots with an antibody to phosphoserine
show no obvious phosphorylation differences, and little
phosphorylation in the region of 87–95 kD (data not
shown). Blots probed for phosphotyrosine show no appre-
ciable phosphorylation at 87–95 kD, but show a band of
heavier phosphorylation at 50 kD in MSH-treated cells
compared with melatonin-treated cells (data not shown).
This difference at 50 kD can also sometimes be seen in
blots probed for phosphothreonine (Fig. 6 B).
As cytoplasmic dynein and kinesin II are present on
melanosomes (Rogers et al., 1997), and since the dynein
intermediate chain has a mol wt of 83 kD in Xenopus (Al-
lan, 1995), and the motor subunits of kinesin II have mol
wts of 85 and 95 kD, respectively, we considered the possi-
bility that the phosphorylated proteins on melanosomes
are the motor proteins themselves. Kinesin II and dynein
were immunoprecipitated from labeled extracts of cells in-
duced to aggregate or disperse melanosomes. The pres-
ence of kinesin II in the immunoprecipitate was verified
by Western blotting with monoclonal antibody K2.4 to the
85-kD subunit of kinesin II, and the presence of dynein
was verified by Western blotting with monoclonal anti-
body 70.1 to the dynein intermediate chain (data not
shown). No consistent phosphorylation differences were
seen in the immunoprecipitations, nor was differential
phosphorylation of the pattern seen on the purified mel-
anosomes observed (Fig. 7). We also probed the immuno-
precipitates with antibodies to phosphothreonine and
phosphoserine and again found neither consistent phos-
phorylation differences nor any phosphorylation like that
seen on melanosomes. Therefore, it is likely that the phos-
phorylation on melanosomes is neither kinesin II nor the
dynein intermediate chain. It is possible, however, that dif-
ferential phosphorylation of the motor proteins occurs
only locally on melanosomes, and it may therefore be nec-
essary to immunoprecipitate the motors from a melanoso-
mal protein fraction rather than from the cell extract.
These experiments, however, have proven difficult to per-
form due to the small amount of protein that we obtain
from a melanosomal fraction, and because extraction of
melanosomes with detergents other than SDS results in
binding of proteins to melanin.
Discussion
The state of aggregation of melanosomes is determined by
the balance between phosphorylation and dephosphoryla-
Figure 6. Phosphorylation of melanosome proteins in cells
treated with 10 nM melatonin, 100 nM MSH, 0.1 mM PMA, or
1 mM IBMX. Phosphorylation differences were reproduced in
three separate experiments. (A) Cells were labeled with 32Pi for
21 h before melanosome purification. The differences in phos-
phorylation are found in the 85–95 kD area. Melanosomal pro-
teins from melatonin-treated cells show phosphorylation at z86,
92, and 95 kD (arrows), whereas proteins from MSH- and IBMX-
treated cells are phosphorylated at 87 and 94 kD. Proteins from un-
treated and PMA-treated cells show phosphorylation in a broad
band from 88–95 kD. (B) Western blot of melanosomal proteins
with the anti-phosphothreonine antibody. The pattern of threonine
phosphorylation looks very similar in the mol wt range 85–95 kD
to the pattern of total phosphorylation in A. There is less phosphor-
ylation on melanosomes purified from cells treated with IMBX
and MSH than on melanosomes purified from cells treated with
melatonin, whereas it appears that untreated and PMA-treated
cells are in a phosphorylation state intermediate between that of
aggregating and dispersing cells. In addition, phosphorylation of
the band at 50 kD is reduced with melatonin treatment.Reilein et al. Regulation of Organelle Transport 811
tion of the proteins that regulate the activity of the motor
proteins on the organelles. Using specific inhibitors to ki-
nases and phosphatases, we investigated the signaling
pathways for melanosome aggregation and dispersion. We
identified PP2A as the phosphatase necessary for pigment
aggregation by expressing the small t antigen and obtain-
ing a nearly complete block of aggregation, and by overex-
pressing PP2A, which inhibited pigment dispersion. These
results are consistent with our results of those of others
(Cozzi and Rollag, 1992; Sammak et al., 1992) showing
that okadaic acid blocks pigment aggregation at concen-
trations that inhibit PP1 or PP2A. The PP2B inhibitors cy-
closporin A, cypermethrin, and fenvalerate had no effect
on melanosome movement, a finding supported by previ-
ous results showing that pigment aggregation in melano-
phores of angelfish (Pterophyllum scalare) and squirrel
fish (Holocentrotus ascensionus) does not require elevated
Ca21 (Sammak et al., 1992; Kotz and McNiven, 1994). In
addition, we expressed specific peptide inhibitors to PP2B
and PP1 and found no effect on aggregation or dispersion.
Previous studies have used pharmacological inhibitors
to analyze the role of PKA and PKC in melanosome mo-
tility. However, most of these inhibitors are capable of in-
hibiting several types of protein kinases, thus limiting the
interpretation of results. We therefore examined pathways
for melanosome aggregation and dispersion using highly
specific recombinant inhibitors of protein kinases; the in-
active variants were used as controls. We found that inhi-
bition of PKA causes melanosomes to spontaneously ag-
gregate and remain at the cell center, indicating that basal
PKA activity is responsible for the normally dispersed
state of the pigment. Moreover, the PKA pathway does
not require PKC, since inhibition of PKC with the recom-
binant inhibitor does not prevent full dispersion of mel-
anosomes upon activation of PKA by MSH.
The PKC pathway can also initiate dispersion, but un-
like the PKA pathway, is insufficient on its own to fully
disperse melanosomes. PKA may be needed for full acti-
vation of a component of the PKC pathway upstream of
the motor proteins. Another possibility is that the PKC
pathway may activate a plus end–directed motor to a sub-
maximal level, allowing partial but not complete disper-
sion. Unlike our observations of partial dispersion induced
by PMA when PKA is inhibited, McClintock et al. (1996)
reported that the PKA inhibitor H89 completely blocked
dispersion through the PKC pathway. Inhibition by H89
may be due to nonspecific inhibition of PKC, as the au-
thors suggest. However, it may be necessary to activate
PKC to a high level to observe partial pigment dispersion
in the absence of PKA activity. McClintock et al. (1996)
activated PKC through hormonal activation of phospholi-
pase C, which may not stimulate PKC to the same extent
as the high concentration of PMA that we used.
Our results agree with previous results suggesting that
the PKA and PKC pathways for pigment dispersion are
distinct. PMA-treated cells assume a morphology different
from cells treated with MSH (Sugden and Rowe, 1992).
Furthermore, in primary cultures of Xenopus melano-
phores, the PKC inhibitor Ro 31-8220 blocked PMA-
induced, but not MSH-induced dispersion of melanosomes
(Sugden and Rowe, 1992). Similarly, in an immortalized
cell line of Xenopus melanophores, Ro 31-8220 blocked
dispersion by an exogenous transfected bombesin receptor
which uses the phospholipase C pathway, but did not
block dispersion by agonists shown to raise intracellular
cAMP, including MSH (McClintock et al., 1996).
PKA appears to mediate the default pathway for pig-
ment dispersion. The dispersed state of melanosomes in
untreated cells does not depend on PKC activity since cells
became completely and permanently aggregated when
transfected with the peptide inhibitor of PKA, but not
when transfected with the peptide inhibitor of PKC. Simi-
larly, angelfish melanophores were induced to aggregate
by microinjection of PKI5–24 (Sammak et al., 1992), and
Xenopus melanophores were induced to partially aggre-
gate with the competitive PKA inhibitor Rp-cAMPS, but
not with the PKC inhibitor Ro 31-8220 (Sugden and
Rowe, 1992).
We transfected melanophores with an inhibitor to
CaMK because a Ca21 elevation accompanying pigment
aggregation has been demonstrated in fish melanophores
(Sammak et al., 1992). However, we found no effect on
melanosome aggregation or dispersion with inhibition of
CaMK. The function of the Ca21 increase in fish melano-
phores is unclear, since aggregation was not blocked when
this increase was suppressed by withdrawal of extracellu-
lar Ca21 or loading of an intracellular Ca21 chelator, nor
was aggregation induced with the calcium ionophore iono-
mycin (Sammak et al., 1992). Similarly, Kotz and McNiven
(1994) showed that a calcium increase is not required for
pigment aggregation in melanophores of squirrel fish.
Considering that a calcium elevation may not be essential
for pigment aggregation, it is not surprising that we de-
tected no effect of CaMK inhibition on melanosome
movement.
The ultimate target for the regulation of melanosome
motility should be on the melanosomes themselves. The
target protein or set of proteins should be involved in
switching the direction the melanosomes travel on micro-
tubules. We looked for differential phosphorylation of
proteins on melanosomes purified from cells treated with
Figure 7. Immunoprecip-
itations of kinesin II and cy-
toplasmic dynein from 32Pi-
labeled melanophore extract.
Left lane, cell extract. Immu-
noprecipitates of dynein from
melatonin-treated and MSH-
treated cells show strong
phosphorylation at the mo-
lecular weights of the dynein
intermediate chain (83 kD)
and the dynein heavy chain,
and at an unidentified band
at 200 kD (arrowheads). Im-
munoprecipitates of kinesin
II from melatonin-treated
and MSH-treated cells have
phosphorylation in a broad
band at 95 kD (bracket). No
consistent phosphorylation
differences have been ob-
served in immunoprecipita-
tions of dynein or kinesin II.The Journal of Cell Biology, Volume 142, 1998 812
melatonin, MSH, IBMX, and PMA, and we found phos-
phorylation differences in a region of mol wt 87–95 kD.
Considering that dispersion requires a kinase whereas ag-
gregation requires a phosphatase, we were surprised by
the heavier phosphorylation on melanosomes from mela-
tonin-treated cells. This result indicates that PKA, PKC,
and PP2A cannot be the only players in the signaling cas-
cades resulting in phosphorylation of melanosomal pro-
teins, and that other kinases and phosphatases in the path-
ways have yet to be identified. It is also interesting to note
that the pattern of phosphorylation on melanosomes from
cells treated with PMA and MSH is different, and supports
the idea that there is a different mechanism of dispersion
by these two pathways. The phosphorylation differences
occur on threonine, since blots with a phosphothreonine
antibody, but not phosphoserine or phosphotyrosine anti-
bodies, showed the same pattern of differential phosphor-
ylation seen in cells labeled with 32Pi.
Potential targets of regulation include the motor pro-
teins themselves, motor-associated proteins such as dynac-
tin, receptors for the motor proteins on the melanosomes,
and microtubule-associated proteins. We did not find dif-
ferential phosphorylation of two motor proteins known to
be present on melanosomes, dynein and kinesin II, when
we immunoprecipitated these proteins from the cell ex-
tract. A myosin motor, myosin V, is present on melano-
somes (Rogers and Gelfand, 1998) and could also be a po-
tential target for regulation, but this motor does not have
any subunits in the 80–90 kD range. The plus and minus
end–directed motors may exist together with the kinases
and phosphatases in a regulatory complex on the melano-
somes, and may therefore be regulated only when present
on the organelles, an arrangement that would maximize
the efficiency and specificity of their regulation. Evidence
for the existence of complexes containing motor proteins
and associated kinases or phosphatases is provided by
many recent studies (Alphey et al., 1997; Blangy et al.,
1995; Karki et al., 1997; Robbins et al., 1997; Nagata et al.,
1998). We hope that by identifying differentially phosphor-
ylated proteins on melanosomes, we will gain some insight
into the mechanism of regulation of melanosome move-
ment.
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